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Abstract

Objectives. The purpose of this study was to assess the relationships between stigma and shame associated
with seeking treatment for sexually transmitted diseases (STDs) and undergoing testing for gonorrhea and
HIV.
Methods. Participants were 847 males and 1126 females (mean age: 24.9 years) in 7 cities. Two scales assessed
STD-related stigma and STD-related shame.
Results. Rates of stigma and shame were higher among participants without a gonorrhea test in the past year
and among those without an HIV test. Sex, age, health service use, previous suspicion of gonorrhea, and low
levels of stigma were independently associated with gonorrhea testing. Age, enrollment site, use of health
services, gonorrhea testing, and low levels of stigma were independently associated with HIV testing.
Conclusions. Shame is part of the experience of seeking STD-related care, but stigma may be a more powerful
barrier to obtaining such care.
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Abstract
Objectives. The purpose of this study was to assess the relationships between stigma and shame
associated with seeking treatment for sexually transmitted diseases (STDs) and undergoing testing for
gonorrhea and HIV.
Methods. Participants were 847 males and 1126 females (mean age: 24.9 years) in 7 cities. Two scales
assessed STDrelated stigma and STDrelated shame.
Results. Rates of stigma and shame were higher among participants without a gonorrhea test in the past
year and among those without an HIV test. Sex, age, health service use, previous suspicion of
gonorrhea, and low levels of stigma were independently associated with gonorrhea testing. Age,
enrollment site, use of health services, gonorrhea testing, and low levels of stigma were independently
associated with HIV testing.
Conclusions. Shame is part of the experience of seeking STDrelated care, but stigma may be a more
powerful barrier to obtaining such care. (Am J Public Health. 2002;92:378–381)
Stigma and shame associated with sexually transmitted diseases (STDs) and HIV infection are
important barriers to appropriate diagnostic and treatment services. For example, in one study, 59% of
men who had never been tested for HIV cited fear of negative social consequences as an important
reason for not seeking testing.1 Stigma may influence pregnant women's refusal to be tested for HIV
despite the benefits of treatment during pregnancy.2,3 Similarly, 44% of the highrisk males in a study
by Woods et al. stated that if namebased reporting were implemented, they would not accept HIV
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1447083/
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testing, and they maintained this intention even after being told of the potential benefits of such
reporting.4 A recent Institute of Medicine report identified stigma as a key element of the “hidden
epidemic” of STDs in the United States.5
Stigma and shame are related but distinct constructs. Stigma is defined as an attribute or label that sets
a person apart from others and links the labeled person to undesirable characteristics.6 Stigma related
to AIDS has been defined as “the prejudice, discounting, discrediting, and discrimination that are
directed at people perceived to have AIDS.”7
An additional implicit characteristic of stigma is that it represents socially shared knowledge
understood even by the targets of the stigmatizing attitudes and behaviors.8 Thus, shame can be an
internalized reaction to stigma.6,9 Shame is defined as a negative emotion elicited when a person
experiences failure in relation to personal or social standards, feels responsible for this failure, and
believes that the failure reflects selfinadequacy rather than inappropriate behavior. The term “self
stigmatization” is sometimes used synonymously with shame to reflect a person's acceptance of the
negative aspects of a stigma.7 Shame is clearly distinguishable, however, from the related negative
affect states of guilt and embarrassment.10
The purpose of this research was to examine relationships of stigma and shame with 2 types of STD
related care: receipt of a test for gonorrhea during the past year and receipt of at least 1 HIV test in the
previous year. Receipt of gonorrhea or HIV screening requires care seeking by individuals and
communication with clinicians that may be affected by stigma, shame, or both. In the case of both
gonorrhea and HIV, screening provides an opportunity for riskreduction interventions among those
who are not infected. Among those found to be infected, effective treatment and control strategies can
reduce the risk of sequelae and limit transmission to others.11,12 STD/HIVrelated care could therefore
be improved through a better understanding of factors such as stigma or shame that may act as barriers
to appropriate screening.

METHODS
Respondents
Data were collected in 1998 as part of the Gonorrhea Community Action Project, a multisite research
program designed to evaluate STDrelated care from the multiple perspectives of clients, providers, and
health care systems. Participating sites included Prince George's County, Maryland; Denver, Colo; Los
Angeles, Calif; Indianapolis, Ind; St. Louis, Mo; Central Harlem, NY; and Birmingham, Ala.
Respondents were recruited from clinics, from communitybased organizations, and through street
intercept in each of the 7 locations. Clinic sites were mainly primary care settings but also included
STD clinics. The street intercept and communitybased organization recruitment strategies targeted
constituencies at high risk for gonorrhea and HIV. Administrators at each research site were asked to
interview an equal number of subjects from each recruitment source. All information was collected via
facetoface interviews requiring 20 to 40 minutes to complete. No effort was made to match
interviewers and respondents in regard to sex, race/ethnicity, age, or sexual preference.
The study protocol was approved by the institutional review boards of the participating sites as well as
the institutional review board of the Centers for Disease Control and Prevention. Written informed
consent was obtained from each participant.
Measures

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1447083/

2/8

6/7/2019

Relationships of Stigma and Shame to Gonorrhea and HIV Screening

Two dependent variables were chosen: gonorrhea testing and HIV testing. Respondents were asked, “In
the past 12 months, how often have you been to a doctor, hospital, or clinic to get tested for
gonorrhea?” A similarly phrased question assessed HIV testing in the past year. Responses to each item
were recoded to represent either “no test in the previous year” or “any (gonorrhea or HIV) test in the
previous year.”
STDrelated stigma and STDrelated shame were measured via items developed for the current
research. A larger set of items was developed to assess personal reactions to STD and STDrelated
testing as well as perceptions of others' responses to these issues. Participants responded on a 5point
Likert scale ranging from strongly disagree to strongly agree. Pilot tests involving 100 volunteers were
conducted to assess factor structure and scale reliability. Items that had factor loadings (i.e.,
correlations with their underlying factor) of .50 and contributed to overall scale reliability were
retained. All factor cross loadings (i.e., correlations with nonunderlying factors) were less than .50.
STDrelated stigma (5 items; α = .77) reflected the participant's expectation of isolation and adverse
social judgment associated with STD. STDrelated shame (6 items; α = .80) reflected the participant's
sense of shame and contamination associated with STD (Table 1▶).

TABLE 1—
Stigma and Shame Measures
Stigma (α = .77)

Shame (α = .80)

I would feel dirty if a doctor examined me for sexually

People with sexually transmitted disease have been

transmitted diseases

hanging with the wrong crowd

Getting a sexually transmitted disease would make me

Getting a sexually transmitted disease means I don't

feel lonely

keep myself clean

Getting examined for a sexually transmitted disease

People with sexually transmitted diseases should be

makes people think I have poor morals

ashamed of themselves

Most people I know think that a sexually transmitted

Getting a sexually transmitted disease means a

disease is a sign of a weak character

person is dirty

Getting a sexually transmitted disease means I have poor

Getting a sexually transmitted disease means I don't

morals

take care of myself
Getting examined for a sexually transmitted disease
means I'm not clean

Items in each scale were summed to create scale scores, with higher scores reflecting greater stigma or
shame. The stigma and shame scales were moderately correlated (r = 0.54), suggesting that they
measured separate but related constructs. Scale scores below the 75th percentile were reclassified as
“low,” and scores above the 75th percentile were reclassified as “high.”
Additional predictor measures included sex, age (14–19, 20–29, 30–39, 40–49, or 50–59 years),
enrollment site (community/health care facility), health service use in the past year (no/yes), and
suspicion of gonorrhea in the past year (no/yes). These variables were selected to control for potential
demographic differences in STDrelated care seeking as well as influences of general use of health care
or STDrelated symptoms. With 2 exceptions, similar models were evaluated for each outcome. For
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1447083/
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gonorrhea testing, previous suspicion of gonorrhea was included to control for symptommotivated
care seeking. For HIV testing, receipt of a gonorrhea test in the past year was entered to control for
routine HIV testing associated with STDrelated visits.
Logistic regression (with 95% confidence intervals for each odds ratio) was used in conducting
statistical analyses. Predictors were entered in a single block. Level of statistical significance was set at
P < .05.

RESULTS
The original sample included 2020 individuals aged 12 to 83 years. Data on sex or age were missing
for 10 participants, and these individuals were excluded from subsequent analyses. In addition, we
restricted the sample to those aged 14 to 59 years to focus on the groups at greatest STD/HIV risk. The
final sample included 1973 respondents (Table 2▶). Missing data reduced the available sample for
some analyses. The majority of participants of both sexes were younger than 39 years. Sixty percent of
the participants were enrolled from health care facilities.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1447083/
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TABLE 2—
Sample Characteristics, by Sex (n = 1973): Gonorrhea Community Action Project, 1998
Males (n = 847), No. (%) Females (n = 1126), No. (%)
Age, y
14–19

281 (33)

445 (40)

20–29

320 (38)

402 (36)

30–39

167 (20)

205 (18)

40–49

60 (7)

57 (5)

50–59

19 (2)

17 (2)

No

541 (65)

820 (74)

Yes

291 (35)

290 (26)

Community

344 (41)

448 (40)

Health facility

500 (59)

675 (60)

No

422 (50)

433 (39)

Yes

424 (50)

693 (61)

No

322 (39)

383 (35)

Yes

497 (61)

714 (65)

Low

621 (73)

852 (76)

High

226 (27)

274 (24)

Low

546 (64)

862 (77)

High

301 (36)

264 (23)

Previous suspicion of gonorrhea*

Enrollment site

Gonorrhea test, past year*

HIV test, past year*

STDrelated stigma

STDrelated shame*

Note. STD = sexually transmitted disease.
*P < .05 (for sex difference).

There were no differences between male and female participants in regard to age or enrollment location
(Table 2▶). Males were more likely than females to have suspected gonorrhea in the past, but females
were more likely than males to have received a gonorrhea or HIV test in the past year. A significantly
higher proportion of males were classified in the “high shame” group.
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Multiple logistic regression analysis showed that gonorrhea testing was independently related to female
sex, younger age, enrollment from a health facility, health service use in the past year, suspicion of
gonorrhea, and low levels of STDrelated stigma (Table 3▶). HIV testing was related to older age,
health service use, gonorrhea testing, and low levels of STDrelated stigma. STDrelated shame was
not related to gonorrhea testing or HIV testing.

TABLE 3—
Predictors of Gonorrhea Testing or HIV Testing in the Past Year (Multiple Logistic
Regression): Gonorrhea Community Action Project, 1998
a
b
Gonorrhea Testing, HIV Testing,
OR (95% CI)

OR (95% CI)

Female (vs male)

1.6 (1.3, 1.9)

0.94 (0.75, 1.2)

Age (in decades)

0.86 (0.78, 0.95)

1.3 (1.1, 1.4)

Clinic (vs community)

1.6 (1.3, 2.0)

1.2 (0.99, 1.5)

Health service use, past year (vs no use)

2.5 (2.0, 3.2)

1.6 (1.2, 2.0)

Gonorrhea history (vs no history)

2.3 (1.9, 2.9)

...

...

8.5 (6.8, 10.6)

High stigma (vs low)

0.77 (0.67, 0.97)

0.66 (0.51, 0.86)

High shame (vs low)

1.1 (0.90, 1.4)

1.2 (0.92, 1.6)

Gonorrhea test, past year (vs no test)

Note. OR = odds ratio; CI = confidence interval.
a

Sample for logistic regression was 1929 owing to listwise deletion of missing data; model χ2 = 190.0; P < .05.

b

Sample for logistic regression was 1903 owing to listwise deletion of missing data; model χ2 = 501.2; P < .05.

DISCUSSION
We found that STDrelated stigma was associated with a decreased likelihood of being tested for
gonorrhea or HIV during the past year. This association was independent of other factors that may
affect testing, such as sex, age, and suspicion of gonorrhea. STDrelated shame was not associated with
receipt of STDrelated care. This is not to say that negative emotions associated with STD/HIVrelated
care are an unimportant element of people's health care experiences.13 Rather, the perception that
others confer negative attributes to those with STD is associated with less than optimal STD/HIV
related care.
Our findings are consistent with widely held assumptions about the role of stigma as a barrier to STD
related care. Our finding that stigma, rather than shame, may be a barrier to STDrelated care seeking
highlights the potential difficulties facing interventions designed to improve STDrelated care seeking.
Increasing knowledge or health care access may not address the barriers posed by STDrelated stigma.4
Communitywide interventions, advocacy, and education might be expected to achieve some gains,

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1447083/
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although the (not uncommon) opinion that acknowledgment and discussion of issues such as STD/HIV
prevention connote approval of proscribed sexual behaviors makes such approaches difficult to
implement.14
Lay health advisors have been suggested as an excellent means for promotion of community norms of
healthy sexuality and STDrelated care.15 However, a substantial body of social psychological research
demonstrates the resistance to change of social stereotypes, especially in regard to conditions judged to
be associated with irresponsible behavior.16 As long as atrisk people perceive adverse judgments
associated with STD, stigma is likely to remain an important barrier to appropriate care.
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